These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Possibilities and limitations of the use of Synacthen Depot Ciba in dermatology]. Ormea F; Muscardin L; Rusciani L; Garcovich A Minerva Med; 1970 Sep; 61(78):4261-7. PubMed ID: 4325284 [No Abstract] [Full Text] [Related]
3. [Therapy of skin- and venereal diseases. Review of the literature 1969]. Walther H Dtsch Med J; 1970 Jun; 21(12):870-6 passim. PubMed ID: 4259633 [No Abstract] [Full Text] [Related]
4. Intermittent tetracosactrin-depot therapy in dermatology. Khan SA; Smith AF Br J Dermatol; 1970 Apr; 82(4):389-96. PubMed ID: 4315091 [No Abstract] [Full Text] [Related]
5. [Use of synthetic ACTH in the therapy of dermatologic diseases]. Schuppli R Dermatologica; 1969; 139(4):243-53. PubMed ID: 4392894 [No Abstract] [Full Text] [Related]
6. [Experience in using a zinc-corticotropin suspension in the therapy of certain dermatoses]. Borisenko KK; Glozman VN Vestn Dermatol Venerol; 1974 May; 48(5):78-80. PubMed ID: 4365447 [No Abstract] [Full Text] [Related]
7. [Synacthen depot in the treatment of some dermatological diseases]. Mazurkiewicz W; D abrowska H Przegl Dermatol; 1972; 59(3):377-82. PubMed ID: 4340580 [No Abstract] [Full Text] [Related]
8. Low-Molecular-Weight Heparins as Immunomodulators in Dermatology Practice. Solak B Am J Ther; 2016; 23(6):e1911-e1917. PubMed ID: 25853237 [TBL] [Abstract][Full Text] [Related]
9. [Advantages and disadvantages of steroid therapy in skin diseases]. Steigleder GK Klin Monbl Augenheilkd; 1966; 148(6):800-10. PubMed ID: 5987288 [No Abstract] [Full Text] [Related]
10. [The introduction of 9,9-dioxopromethazine (Prothanon) into the treatment of skin diseases in hospitalized patients]. Nitzschner H Pharmazie; 1970 Feb; 25(2):111-3. PubMed ID: 4393059 [No Abstract] [Full Text] [Related]
11. [On the use of a new emulsion of corticosteroids in the treatment of a series of dermatitis cases]. Scarpa C; Ferrea E Minerva Dermatol; 1968 Oct; 43(10):484-8. PubMed ID: 4237977 [No Abstract] [Full Text] [Related]
12. [The oral corticosteroid treatment of "benign" dermatoses]. Jadassohn W; Musso E Munch Med Wochenschr; 1967 Jul; 109(29):1539-41. PubMed ID: 4232480 [No Abstract] [Full Text] [Related]
13. [Tiapride in dermatology]. Michel F Sem Hop; 1979 Feb 8-15; 55(5-6):305-7. PubMed ID: 219545 [TBL] [Abstract][Full Text] [Related]
15. [Clinical experience with a new antihistaminic]. Wolfram S Wien Med Wochenschr; 1967 Sep; 117(38):868-70. PubMed ID: 4385553 [No Abstract] [Full Text] [Related]
16. [Therapy of chronic refractory skin diseases with synthetic ACTH, Cortrocin-depot]. Hayakawa M Hifuka Kiyo; 1970 Feb; 65(1):51-61. PubMed ID: 4321317 [No Abstract] [Full Text] [Related]
17. [Dermatology and climatic therapy with special reference to the Davos climate]. Brenn H Dermatologica; 1969; 139(4):278-85. PubMed ID: 4246136 [No Abstract] [Full Text] [Related]
18. USE OF CYPROHEPTADINE AND CYPROHEPTADINE-DEXAMETHASONE COMBINATION IN DERMATOLOGIC DISORDERS. GRAYSON LD; SHAIR HM Clin Med (Northfield); 1964 Apr; 71():713-6. PubMed ID: 15446150 [No Abstract] [Full Text] [Related]
19. [Problems of climatotherapy in dermatoses. Indications and chances of success]. Borelli S Munch Med Wochenschr; 1969 Aug; 111(35):1709-17. PubMed ID: 4241287 [No Abstract] [Full Text] [Related]
20. [Clinical experience with a new corticosteroid for topical use: formocortal]. Buzzoni A; Guarneri B G Ital Dermatol Minerva Dermatol; 1969 Dec; 44(12):673-6. PubMed ID: 4243641 [No Abstract] [Full Text] [Related] [Next] [New Search]